Roberto Carlesi
Impact in
- Gastroenterology top 1%
- Gastrointestinal Tumor Research and Treatment
-
- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies
Papers in
-
- Gastric Cancer Management and Outcomes 7
- Lung Cancer Treatments and Mutations 2
- Surgery 7
- Helicobacter pylori-related gastroenterology studies 2
- Co-authors
- Kei Muro (6 shared papers)Kumari Chandrawansa (5 shared papers)Yasuhiro Shimada (5 shared papers)Atsushi Ohtsu (6 shared papers)Eric Van Cutsem (6 shared papers)Michael Emig (4 shared papers)Philippe Rougier (3 shared papers)G. Bodoky (5 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)The Oncologist (2 papers)Cancer Research and Treatment (1 paper)The Lancet Oncology (1 paper)Journal of Gastroenterology and Hepatology (1 paper)
- Partner nations
- ItalyUnited StatesSouth Korea
In The Last Decade
Roberto Carlesi
15 papers receiving 1.9k citations
Roberto Carlesi's Hit Papers
Peers
Comparison fields: 5 of 77
- Gastroenterology 539
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 1.0k
- Surgery 657
- Pathology and Forensic Medicine 213
Countries citing papers authored by Roberto Carlesi
This map shows the geographic impact of Roberto Carlesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Carlesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Carlesi more than expected).
Fields of papers citing papers by Roberto Carlesi
This network shows the impact of papers produced by Roberto Carlesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Carlesi. The network helps show where Roberto Carlesi may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Carlesi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Hit paper breakdown → | 2014 | 1715 |
| 2 | 2014 | 65 | |
| 3 | 2017 | 51 | |
| 4 | 2015 | 31 | |
| 5 | 1992 | 26 | |
| 6 | 2020 | 23 | |
| 7 | 2014 | 14 | |
| 8 | 2020 | 8 | |
| 9 | 2015 | 5 | |
| 10 | 1993 | 5 | |
| 11 | 2020 | 4 | |
| 12 | 1995 | 2 | |
| 13 | 1994 | 2 | |
| 14 | 1990 | 2 | |
| 15 | 2019 | 1 |
About Roberto Carlesi
Roberto Carlesi is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Biology and Gastroenterology, having authored 15 papers that have together received 2.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Analytical Chemistry and Chromatography (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Sesquiterpenes and Asteraceae Studies (2 papers). The work is most often cited by research in Gastroenterology (539 citations), Pulmonary and Respiratory Medicine (1.4k citations), Oncology (1.0k citations), Surgery (657 citations) and Pathology and Forensic Medicine (213 citations). Roberto Carlesi has collaborated with scholars based in Italy, United States and South Korea. Frequent co-authors include Kei Muro, Kumari Chandrawansa, Yasuhiro Shimada, Atsushi Ohtsu, Eric Van Cutsem, Michael Emig, Philippe Rougier, G. Bodoky, H. Wilke and David Cunningham. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Cancer Research and Treatment, The Lancet Oncology and Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.